financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Sell Opinion On Shares Of Canadian Imperial Bank Of Commerce
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Sell Opinion On Shares Of Canadian Imperial Bank Of Commerce
Mar 4, 2024 11:01 PM

10:35 AM EST, 02/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price by USD4 to USD38, 8.0x our FY 2025 (Oct.) EPS view (USD4.80 converted from CAD), a warranted discount to the peer average of 9.9x given weaker credit quality and softer earnings expectations. We increase our FY 2025 EPS to CAD6.88 from CAD6.53 and raise FY 2025's to CAD6.51 from CAD6.47. CM posted adjusted Jan-Q EPS of CAD1.81 vs. CAD1.94 a year ago, beating the CAD1.67 consensus. Revenue jumped 5% Y/Y, driven by margin expansion, volume growth, higher fee income, and strong trading revenues. However, with gross impaired loans coming in at 55 bps (about 20% above historic levels), we continue to take a cautious view on shares as we expect customers to struggle with elevated debt service ratios. Still, it was an encouraging quarter as CM improved its resilience by increasing its capital levels (CET1 ratio +130 bps Y/Y to 13.0%). Additionally, the bank's allowance for credit losses is up 24% Y/Y, while CM has reduced its U.S. commercial real estate loan exposure by 12%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Lincoln National Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Lincoln National Corporation
Oct 30, 2025
09:45 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: LNC posted Q3 operating EPS of $2.04 vs. $2.06, topping our $1.80 EPS estimate and the $1.87 consensus view. Operating revenues rose 10.8% vs. our 3%-6% growth forecast, driven by...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Meta Platforms
Research Alert: CFRA Maintains Buy Opinion On Shares Of Meta Platforms
Oct 30, 2025
08:25 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target to $804 from $880, on lower P/E of 24x our '27 EPS view, within historical. After better-than-expected Q3 sales/EPS (ex. one-time tax charge), we up...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Microsoft Corporation
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Microsoft Corporation
Oct 30, 2025
07:05 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $620, on a P/E of 31.1x our CY 27 view of $19.93, near its five-year historical forward average. After posting better-than-expected Sep-Q results,...
Research Alert: CFRA Raises Opinion On Adss Of Gsk To Buy From Hold
Research Alert: CFRA Raises Opinion On Adss Of Gsk To Buy From Hold
Oct 30, 2025
06:20 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our opinion on GSK to Buy from Hold and revise our target price to USD53 from USD40 following strong Q3 results and a guidance upgrade, which sits at...
Copyright 2023-2025 - www.financetom.com All Rights Reserved